Activated protein C resistance
Activated protein C resistance is a hemostatic disordercharacterized by a poor anticoagulantresponse to activated protein C(APC). This results in an increased risk of venous thrombosis.
Activated protein C (with protein S as a cofactor) degrades Factor Vaand Factor VIIIa. Activated protein C resistance is the inability of protein C to cleave factors V and/or VIII. This may be hereditary or acquired. The best known and most common hereditary form is Factor V Leiden. Acquired forms occur in the presence of elevated Factor VIII concentrations.
In most cases, APC resistance is associated with a single missense mutation in the gene for coagulation factor V (FV (Leiden)). It has been estimated that up to 64% of patients with venous thromboembolism might have activated protein C resistance.
References
|test={{{Authorlink|}}}
|then={{wikilink
|1={{{Authorlink}}}
|2={{{Author|{{{Last|}}}{{{else{{{test|}}}|{{{test{{{test|}}}|{{{then|}}}}}}}}}}|then=, {{{First}}}}}}}}
}}
|else={{{Author|{{{Last|}}}{{{else{{{test|}}}|{{{test{{{test|}}}|{{{then|}}}}}}}}}}|then=, {{{First}}}}}}}}
}}{{qif
|test={{{Coauthors|}}}
|then=, {{{Coauthors}}}
}}{{qif
|test={{{Date|}}}
|then= ({{{Date}}})
|else={{qif
|test={{{Year|}}}
|then={{qif
|test={{{Month|}}}
|then= ({{{Month}}} 2003)
|else= (2003)
}}
}}
}}{{qif
|test={{{Author|{{{Last|{{{Year|}}}}}}}}}
|then=.
}}{{qif
|test={{{URL|}}}
|then=[{{{URL}}}
|else=
}} Congenital and acquired activated protein C resistance{{qif
|test={{{URL|}}}
|then=]
|else=
}}{{qif
|test={{{Journal|}}}
|then=. Semin Vasc Med
}}{{qif
|test={{{Volume|}}}
|then= 3
}}{{qif
|test={{{Issue|}}}
|then= (1)
}}{{qif
|test={{{Pages|}}}
|then=: 33-46
}}{{qif
|test={{{ID|}}}
|then=. {{{ID}}}
}}. PMID 15199491
|test={{{Authorlink|}}}
|then={{wikilink
|1={{{Authorlink}}}
|2={{{Author|{{{Last|}}}{{{else{{{test|}}}|{{{test{{{test|}}}|{{{then|}}}}}}}}}}|then=, {{{First}}}}}}}}
}}
|else={{{Author|{{{Last|}}}{{{else{{{test|}}}|{{{test{{{test|}}}|{{{then|}}}}}}}}}}|then=, {{{First}}}}}}}}
}}{{qif
|test={{{Coauthors|}}}
|then=, {{{Coauthors}}}
}}{{qif
|test={{{Date|}}}
|then= ({{{Date}}})
|else={{qif
|test={{{Year|}}}
|then={{qif
|test={{{Month|}}}
|then= ({{{Month}}} 2003)
|else= (2003)
}}
}}
}}{{qif
|test={{{Author|{{{Last|{{{Year|}}}}}}}}}
|then=.
}}{{qif
|test={{{URL|}}}
|then=[{{{URL}}}
|else=
}} The discovery of activated protein C resistance{{qif
|test={{{URL|}}}
|then=]
|else=
}}{{qif
|test={{{Journal|}}}
|then=. J Thromb Haemost
}}{{qif
|test={{{Volume|}}}
|then= 1
}}{{qif
|test={{{Issue|}}}
|then= (1)
}}{{qif
|test={{{Pages|}}}
|then=: 3-9
}}{{qif
|test={{{ID|}}}
|then=. {{{ID}}}
}}. PMID 12871530
|test={{{Authorlink|}}}
|then={{wikilink
|1={{{Authorlink}}}
|2={{{Author|{{{Last|}}}{{{else{{{test|}}}|{{{test{{{test|}}}|{{{then|}}}}}}}}}}|then=, {{{First}}}}}}}}
}}
|else={{{Author|{{{Last|}}}{{{else{{{test|}}}|{{{test{{{test|}}}|{{{then|}}}}}}}}}}|then=, {{{First}}}}}}}}
}}{{qif
|test={{{Coauthors|}}}
|then=, {{{Coauthors}}}
}}{{qif
|test={{{Date|}}}
|then= ({{{Date}}})
|else={{qif
|test={{{Year|}}}
|then={{qif
|test={{{Month|}}}
|then= ({{{Month}}} 2000)
|else= (2000)
}}
}}
}}{{qif
|test={{{Author|{{{Last|{{{Year|}}}}}}}}}
|then=.
}}{{qif
|test={{{URL|}}}
|then=[{{{URL}}}
|else=
}} Activated protein C resistance: the most common risk factor for venous thromboembolism{{qif
|test={{{URL|}}}
|then=]
|else=
}}{{qif
|test={{{Journal|}}}
|then=. J Am Board Fam Pract
}}{{qif
|test={{{Volume|}}}
|then= 13
}}{{qif
|test={{{Issue|}}}
|then= (2)
}}{{qif
|test={{{Pages|}}}
|then=: 111-5
}}{{qif
|test={{{ID|}}}
|then=. {{{ID}}}
}}. PMID 10764192
External links
Categories: Disease stubs| Hematology
This article is licensed under the GNU Free Documentation License. It uses material from the http://en.wikipedia.org/wiki/Activated+protein+C+resistance Wikipedia article Activated protein C resistance.
|